pfizer glp-1 pipeline has released promising mid-stage Phase IIb trial data for its obesity treatment, PF-3944. This long-acting injectable demonstrated an impressive 12.3% placebo-adjusted weight loss at 28 weeks with monthly dosing, positioning GLP-1 Pipeline Update: February 2025

Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae

While it might feel counterintuitive to eat while nauseous, Laura says consuming small meals can help you settle your stomach and reduce discomfort. Pay attention to your body and identify which foods you can tolerate when feeling nauseous, she advises

Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats

The critical question is: what happens when women who already have low glutathione status take Tylenol during the critical window of fetal brain development

Research shows measurable glutathione reduction occurs at doses above 2,000 mg/day and risk escalates with chronic daily use